How the management of CLL is evolving
How can the study of familial leukemias help us to understand sporadic leukemias?
Jane E. Churpek
Novel biological therapies for managing non-Hodgkin lymphoma
The importance of recgonizing different DLBCL subtypes
A new prognostic tool for CLL: CLL-IPI